Invuity Inc. Showcased PhotonBlade at Premier Inc.’s Annual Breakthroughs Conference

SAN FRANCISCO, July 12, 2017 (GLOBE NEWSWIRE) -- Invuity’s (Nasdaq:IVTY) PhotonBlade, precision illuminator with next-generation enhanced energy, is one of the medical innovations that was showcased in front of thousands of healthcare providers at Premier Inc.’s 2017 Breakthroughs Conference and Exhibition on June 27. 

PhotonBlade was debuted during the conference’s annual Innovation Celebration. The event recognizes advances in healthcare while highlighting industry suppliers committed to innovation and improving patient outcomes.

“Invuity shares Premier’s commitment to providing valuable products to our alliance members that are safe, high-quality and cost-effective,” said Durral R. Gilbert, president of supply chain services, Premier. “We believe these innovations can benefit providers as they work to transform healthcare.”

Clinicians and other health system members of Premier selected PhotonBlade to be showcased at the Innovation Celebration due to its uniqueness, ability to have an impact on unmet clinical needs and potential to improve patient care.

For surgeons who perform minimal access surgery, PhotonBlade provides direct, thermally cool illumination at the precise point of surgical treatment. Further, PhotonBlade’s novel energy platform consists of a proprietary coated blade for precise cutting and coagulation of tissue, with minimal collateral effect. This sophisticated illumination technology further allows for unique use in a fluid filled environment and does not require a proprietary generator, thereby leveraging widely available operating room equipment and avoiding an institutional capital investment. PhotonBlade provides exceptional visualization within the surgical cavity, for precision and safety.

“We are honored to have received this recognition from Premier,” stated President and CEO of Invuity Philip Sawyer. “It demonstrates the consistent goals of both Invuity and Premier in constantly striving to provide the best possible care for patients. We will continue to develop innovative technology for healthcare providers that positively impacts patient lives.” 

Any supplier, regardless of whether the company is contracted with Premier, can be considered for participation in the Innovation Celebration. Premier contracts with more than 1,200 suppliers.

For more detailed information, including a video of PhotonBlade visit: http://breakthroughs.premierinc.com/innovation-celebration-2017/

About Premier Inc.
Premier Inc. is a leading healthcare improvement company, uniting an alliance of approximately 3,750 U.S. hospitals and more than 130,000 other provider organizations. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Please visit Premier’s news and investor sites on www.premierinc.com.

About Invuity® Inc.
Invuity, Inc. is a leading medical technology company focused on developing and marketing advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The company's proprietary Intelligent Photonics™ technology delivers enhanced visualization which facilitates surgical precision, efficiency and safety. In addition, the company utilizes comprehensive strategic marketing programs to create stronger institutional partnerships. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic, and general surgery. Invuity is headquartered in San Francisco, CA. For more information, visit invuity.com.

Forward-Looking Statements

This announcement contains forward-looking statements that involve risks and uncertainties, including statements regarding expectations for PhotonBlade, future product development and our commercial strategies. Actual results could differ materially from those projected in the forward-looking statements as a result of certain risk factors, including, but not limited to: fluctuations in demand or failure to gain market acceptance for the Company's devices; the Company's ability to demonstrate to and gain approval from hospitals to use the Company's devices; the highly competitive business environment for surgical medical devices; the Company's ability to sell its devices at prices that support its current business strategies; difficulty forecasting future financial performance; protection of the Company's intellectual property; and compliance with necessary regulatory clearances or approvals. The Company undertakes no obligation to update the forward-looking information in this release. More information about potential factors that could affect the Company's business and financial results is included in its filings with the Securities and Exchange Commission, including, without limitation, under the captions: "Management's Discussion and Analysis of Financial Condition and Results of Operations," and "Risk Factors," which are on file with the Securities and Exchange Commission.

CONTACT:
Company Contact:
Jim Mackaness
Chief Financial Officer
Invuity, Inc.
415-655-2129

Investors:
Mark Klausner
Westwicke Partners
443-213-0501
irdept@invuity.com

Primary Logo

Invuity